The price cut brings the cost down to 2008 levels, the drugmaker said, and will apply to all Eli Lilly’s non-branded insulins.
The list price for insulin lispro will be $82.41 for individual vials and $159.12 for a pack of five pens.
Eli Lilly said people who face higher out-of-pocket costs, such as those without insurance or with high deductible health plans, will benefit the most from the price drop.
Read the full news release here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
